360 related articles for article (PubMed ID: 12768833)
1. [Long-term treatment with low molecular weight heparin, of chronic disseminated intravascular coagulation].
García Fernández JR; López Berenguel F; Ais C
An Med Interna; 2003 Apr; 20(4):191-4. PubMed ID: 12768833
[TBL] [Abstract][Full Text] [Related]
2. [The treatment with low-molecular-weight heparin of disseminated intravascular coagulation secondary to an aortic aneurysm].
Callejas Rubio JL; Ortego Centeno N; Díez Ruiz A; Bermúdez García JM
Rev Clin Esp; 1998 Nov; 198(11):781-2. PubMed ID: 9883061
[No Abstract] [Full Text] [Related]
3. Low molecular weight heparin treatment decreases MMP-9 plasma activity in patients with abdominal aortic aneurysm.
Grzela T; Brawura-Biskupski-Samaha R; Jelenska MM; Szmidt J
Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):159-61. PubMed ID: 17964826
[TBL] [Abstract][Full Text] [Related]
4. Treatment of disseminated intravascular coagulation with low molecular weight heparin. Research Group of FR-860 on DIC in Japan.
Oguma Y; Sakuragawa N; Maki M; Hasegawa H; Nakagawa M
Semin Thromb Hemost; 1990 Oct; 16 Suppl():34-40. PubMed ID: 1962902
[TBL] [Abstract][Full Text] [Related]
5. [Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm].
Yoneda K; Amano I; Tanaka H; Yagi H; Tsukaguchi N; Morii T; Narita N
Rinsho Ketsueki; 2001 Jan; 42(1):30-4. PubMed ID: 11235131
[TBL] [Abstract][Full Text] [Related]
6. Expert consensus for the treatment of disseminated intravascular coagulation in Japan.
Wada H; Asakura H; Okamoto K; Iba T; Uchiyama T; Kawasugi K; Koga S; Mayumi T; Koike K; Gando S; Kushimoto S; Seki Y; Madoiwa S; Maruyama I; Yoshioka A;
Thromb Res; 2010 Jan; 125(1):6-11. PubMed ID: 19782389
[TBL] [Abstract][Full Text] [Related]
7. [A successfully treated case of thoracoabdominal aortic aneurysm complicated with the coagulation disorder].
Ohsawa T; Tsubota M; Endo M; Kobayashi K; Sato H; Seki M
Kyobu Geka; 1995 Aug; 48(9):776-80. PubMed ID: 7564042
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of low molecular weight heparin in a canine model of thromboplastin-induced acute disseminated intravascular coagulation.
Mischke R; Fehr M; Nolte I
Res Vet Sci; 2005 Aug; 79(1):69-76. PubMed ID: 15894027
[TBL] [Abstract][Full Text] [Related]
9. [Monitoring of plasma concentration of low molecular weight heparin--comparative evaluation with chromogenic and clotting assays].
Katagiri H; Itoh S; Uchida T; Kawai Y; Watanabe K
Rinsho Byori; 1999 Nov; 47(11):1046-51. PubMed ID: 10590682
[TBL] [Abstract][Full Text] [Related]
10. Trial of low molecular weight heparin in the treatment of viper bites.
Paul V; Pudoor A; Earali J; John B; Anil Kumar CS; Anthony T
J Assoc Physicians India; 2007 May; 55():338-42. PubMed ID: 17844693
[TBL] [Abstract][Full Text] [Related]
11. Disseminated intravascular coagulation in cancer patients.
Levi M
Best Pract Res Clin Haematol; 2009 Mar; 22(1):129-36. PubMed ID: 19285279
[TBL] [Abstract][Full Text] [Related]
12. [Thoracic aortic aneurysm with chronic disseminated intravascular coagulation treated successfully with orally administered camostat mesilate, warfarin and aspirin].
Fukuda N; Shimohakamada Y; Nakamori Y; Tominaga T; Shinohara K; Takahashi T; Oeda E; Sato Y
Rinsho Ketsueki; 2002 Mar; 43(3):199-203. PubMed ID: 11979753
[TBL] [Abstract][Full Text] [Related]
13. Long-term management of chronic DIC associated with inoperable aortic aneurysm with low molecular weight heparin.
Majumdar G
Hematol J; 2004; 5(5):447-8. PubMed ID: 15448673
[TBL] [Abstract][Full Text] [Related]
14. [Heparin, low molecular weight heparin, heparinoid, and antithrombin III therapy of disseminated intravascular coagulation].
Nakagawa M
Nihon Rinsho; 1993 Jan; 51(1):87-92. PubMed ID: 7679453
[TBL] [Abstract][Full Text] [Related]
15. [Activation of coagulation and fibrinolysis in patients with abdominal true aortic aneurysm associated with disseminated intravascular coagulation].
Akaike M; Yokoi K; Wada M; Sebe T; Shigekiyo T; Kawai H; Saito S
Kokyu To Junkan; 1993 Mar; 41(3):267-70. PubMed ID: 8469833
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic chronic DIC controlled with low-molecular-weight heparin.
Majumdar G
Blood Coagul Fibrinolysis; 1996 Jan; 7(1):97-8. PubMed ID: 8845470
[TBL] [Abstract][Full Text] [Related]
17. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: comparison with low molecular weight heparin.
Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Watanabe M; Mochizuki H
Thromb Haemost; 1997 Apr; 77(4):789-95. PubMed ID: 9134660
[TBL] [Abstract][Full Text] [Related]
18. Heparin and low-molecular-weight heparin.
Gray E; Mulloy B; Barrowcliffe TW
Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
[TBL] [Abstract][Full Text] [Related]
19. Acute generalized, widespread bleeding. Diagnosis and management.
Rocha E; Páramo JA; Montes R; Panizo C
Haematologica; 1998 Nov; 83(11):1024-37. PubMed ID: 9864925
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation.
Slofstra SH; van 't Veer C; Buurman WA; Reitsma PH; ten Cate H; Spek CA
Crit Care Med; 2005 Jun; 33(6):1365-70. PubMed ID: 15942357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
